/**
 * Quick Review content for Topic 32 - Biology of the airways. Metabolic and endocrine functions of the lung.
 * Auto-generated by Quick Review Generator
 */
const topic32QuickReview = {
  topicId: 'topic-32',
  topicNumber: 32,
  learningObjectives: {
    'lo-1': {
      title: 'Describe the function of the nasal turbines. Characterize the sneezing and the coughing reflex.',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'Nasal Turbinates (Conchae)' },
        { type: 'list', intro: 'Four key functions of nasal turbinates:', items: [
          'Air filtration: Mucus and cilia trap particles, pathogens',
          'Air humidification: Moistens air to protect lower airways',
          'Air warming: Rich blood supply warms air to near body temp',
          'Airflow regulation: Curved shape creates turbulence for better air conditioning'
        ]},
        { type: 'header', text: 'Protective Reflexes' },
        { type: 'comparison',
          left: {
            title: 'Sneezing Reflex',
            items: [
              'Clears upper airways (nasal cavity)',
              'Trigger: Nasal mucosa irritation (dust, pollen)',
              'Pathway: CN V (trigeminal) → medulla',
              'Mechanism: Deep breath → glottis closure → pressure buildup → forceful expulsion',
              'Speed: ~100 mph through nose/mouth'
            ]
          },
          right: {
            title: 'Coughing Reflex',
            items: [
              'Clears lower airways (larynx, trachea, bronchi)',
              'Trigger: Respiratory epithelium irritation (smoke, mucus)',
              'Pathway: CN X (vagus) → medulla',
              'Mechanism: Deep breath → glottis closure → muscle contraction → explosive exhalation',
              'Effect: Dislodges and expels irritants'
            ]
          }
        },
        { type: 'keypoint', text: 'Both reflexes are protective mechanisms expelling irritants from different regions of the respiratory tract' }
      ]
    },
    'lo-2': {
      title: '>>Define the term mucociliary clearance.<<',
      isCritical: true,
      blocks: [
        { type: 'header', text: 'Mucociliary Clearance', critical: true },
        { type: 'keypoint', text: 'Essential defense mechanism: coordinated mucus production + ciliary movement to remove inhaled particles, pathogens, and debris from airways', critical: true },
        { type: 'steps', intro: 'Mechanism of action:', items: [
          'Mucus layer (goblet cells + submucosal glands) traps particles and microorganisms',
          'Cilia (hair-like projections) beat at 10 Hz in coordinated wave-like manner',
          'Mucus + trapped particles move upward toward pharynx at ~1 mm/min',
          'Material transported to throat → swallowed or expelled'
        ]},
        { type: 'header', text: 'Particle Fate by Size' },
        { type: 'table', headers: ['Particle Size', 'Location Reached'], rows: [
          ['> 5 µm', 'Upper airways (trapped)'],
          ['5-2 µm', 'Bronchioles'],
          ['< 2 µm', 'Alveoli']
        ]},
        { type: 'list', intro: 'Factors impairing clearance (→ atelectasis, infections, hypoxia):', items: [
          'Vagus nerve stimulation',
          'Temperature extremes (cold/heat)',
          'Smoking',
          'Dehydration, dry air',
          'Anesthesia',
          'Drugs'
        ]},
        { type: 'clinical', text: 'Impaired mucociliary clearance leads to atelectasis, respiratory infections, and hypoxia' }
      ]
    },
    'lo-3': {
      title: 'Protection of the lung and the airways: describe functions alveolar macrophages, Clara-cells, tissue mast cells.',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'Cellular Defense Systems' },
        { type: 'header', text: 'Alveolar Macrophages' },
        { type: 'paragraph', text: 'Essential immune cells in alveolar spaces that phagocytize inhaled particles (dust, smoke, silicium, asbestos)' },
        { type: 'comparison',
          left: {
            title: 'Digestible Particles',
            items: [
              'Broken down by lysosomes',
              'By-products released to lymphatics',
              'Maintains clean alveolar environment'
            ]
          },
          right: {
            title: 'Non-digestible Particles',
            items: [
              'Encapsulated in "giant cell" capsule',
              'Prevents harm to tissue',
              'Held until potentially dissolved over time'
            ]
          }
        },
        { type: 'header', text: 'Clara Cells (Club Cells)' },
        { type: 'list', intro: 'Located in bronchiolar epithelium with three key functions:', items: [
          'Surfactant production: Reduce surface tension, prevent bronchiolar collapse',
          'Detoxification: Enzymatic properties neutralize harmful inhaled substances',
          'Regeneration: Act as progenitor stem cells to replace damaged epithelial cells'
        ]},
        { type: 'header', text: 'Tissue Mast Cells' },
        { type: 'paragraph', text: 'Located in lung connective tissue; pivotal role in allergic reactions and immune defense' },
        { type: 'list', intro: 'Release mediators during allergic reactions:', items: [
          'Histamine → bronchoconstriction, mucus production, airway inflammation',
          'Leukotrienes → prolonged allergic response, sustained bronchoconstriction'
        ]},
        { type: 'clinical', text: 'Excessive mast cell activation contributes to airway obstruction in asthma and allergic conditions' }
      ]
    },
    'lo-4': {
      title: '>>Describe the control of airway diameter and secretory activity: Define the term bronchomotor tone. Adrenergic effects.<< Describe the effects mediated by adrenergic receptors. Describe the effect of inflammatory mediators (histamine, prostanoids, leucotrienes).',
      isCritical: true,
      blocks: [
        { type: 'header', text: 'Bronchomotor Tone', critical: true },
        { type: 'keypoint', text: 'Baseline level of smooth muscle tension in bronchial walls determining airway diameter; constantly regulated by autonomic nervous system', critical: true },
        { type: 'paragraph', text: 'Parasympathetic tone (vagus nerve): Maintains resting baseline constriction with diurnal rhythm → early morning asthma' },
        { type: 'header', text: 'Adrenergic Receptor Effects' },
        { type: 'comparison',
          left: {
            title: 'β₂-Adrenergic (Predominant)',
            items: [
              'Location: Bronchial smooth muscle, glandular epithelium',
              'Agonist: Circulating epinephrine',
              'Effect: Bronchodilation (relaxes smooth muscle)',
              'Inhibits mucus secretion (drying effect)',
              'Inhibits mast cell degranulation (anti-inflammatory)',
              'Clinical use: β₂-agonists (salbutamol) for asthma/COPD'
            ]
          },
          right: {
            title: 'α-Adrenergic (Minor)',
            items: [
              'Location: Nasal mucosa, submucosal vessels',
              'Effect: Vasoconstriction in nasal passages',
              'Clinical use: Decongestants',
              'Minor role in lower airways',
              '',
              ''
            ]
          }
        },
        { type: 'header', text: 'Inflammatory Mediators' },
        { type: 'table', headers: ['Mediator', 'Source', 'Effects'], rows: [
          ['Histamine', 'Mast cells, basophils', 'Bronchoconstriction (H₁), ↑ vascular permeability → edema, ↑ mucus'],
          ['PGD₂', 'Arachidonic acid metabolism', 'Bronchoconstriction'],
          ['PGE₂', 'Arachidonic acid metabolism', 'Bronchodilation OR constriction (receptor-dependent)'],
          ['Leukotrienes (LTC₄, LTD₄)', 'Mast cells, eosinophils', 'Potent/prolonged bronchoconstriction, ↑ mucus, edema']
        ]},
        { type: 'clinical', text: 'Leukotriene receptor antagonists (e.g., montelukast) used in asthma therapy target the potent bronchoconstrictor effects' }
      ]
    },
    'lo-5': {
      title: 'Describe the clearance of vasoactive substances by the pulmonary circulation. Give examples for substances that are virtually fully "cleared" (local mediators: leucotrienes, prostanoids, bradykinin, VIP, endothelin, serotonin, and also for substances that pass effectively unchanged (the vasoactive hormones: adrenaline, vasopressin).',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'Pulmonary Endothelial Filtering' },
        { type: 'paragraph', text: 'Pulmonary capillary endothelium (Ø ~7 µm) filters and metabolizes vasoactive substances entering lungs with venous blood' },
        { type: 'header', text: 'Substances Virtually Fully Cleared (Local Mediators)' },
        { type: 'table', headers: ['Substance', 'Mechanism', 'Function'], rows: [
          ['Leukotrienes', 'Inactivated', 'Bronchoconstriction/inflammation'],
          ['Prostanoids (PGF₂α)', 'Metabolized', 'Vasodilation/inflammation'],
          ['Bradykinin', 'Degraded by ACE', 'Vascular permeability'],
          ['VIP', 'Inactivated', 'Smooth muscle relaxation'],
          ['Endothelin', 'Partially removed', 'Potent vasoconstrictor'],
          ['Serotonin (5-HT)', '~80% uptake by endothelium/platelets', 'Vasoactive effects']
        ]},
        { type: 'header', text: 'Substances Passing Unchanged (Systemic Hormones)' },
        { type: 'list', intro: 'Vasoactive hormones that pass through lungs unchanged:', items: [
          'Adrenaline (epinephrine) → systemic hormone',
          'Vasopressin (ADH) → systemic hormone'
        ]},
        { type: 'header', text: 'Special Case: Activation vs Clearance' },
        { type: 'keypoint', text: 'Angiotensin I → converted to Angiotensin II by ACE (activation, not clearance)' },
        { type: 'clinical', text: 'Lung also plays role in hemostasis: produces plasminogen activators, heparin, and thromboplastin' }
      ]
    },
    'lo-6': {
      title: 'Describe the importance of pulmonary vascular endothelium in the production of angiotensin II (ACE expression).',
      isCritical: false,
      blocks: [
        { type: 'header', text: 'ACE Expression in Pulmonary Endothelium' },
        { type: 'keypoint', text: 'Pulmonary endothelium = one of most significant sites for ACE expression; strategic location ensures efficient Angiotensin I → Angiotensin II conversion' },
        { type: 'steps', intro: 'Conversion process as blood flows through lungs:', items: [
          'Blood containing Angiotensin I (inactive decapeptide) enters pulmonary capillaries',
          'ACE on endothelial surface catalyzes conversion to Angiotensin II (active octapeptide)',
          '~70-80% of circulating Angiotensin I converted in single pass through lungs',
          'Angiotensin II released into systemic circulation'
        ]},
        { type: 'header', text: 'Angiotensin II Functions (RAAS System)' },
        { type: 'list', intro: 'Critical role in blood pressure and fluid balance:', items: [
          'Potent vasoconstriction → ↑ systemic vascular resistance and BP',
          'Stimulates adrenal cortex → aldosterone secretion → Na⁺/H₂O retention',
          'Influences fluid and electrolyte balance → maintains homeostasis'
        ]},
        { type: 'clinical', text: 'ACE inhibitors block this conversion to treat hypertension; pulmonary endothelium essential for BP regulation during dehydration/blood loss' },
        { type: 'formula', formula: 'Angiotensin I → ACE → Angiotensin II', explanation: 'Blood pressure control pathway' }
      ]
    }
  }
};

export default topic32QuickReview;
